J Rheumatol
-
To describe the longterm safety and efficacy profile of tofacitinib in patients with moderate to severe active rheumatoid arthritis (RA). ⋯ Tofacitinib demonstrated consistent safety and persistent efficacy over 48 months in patients with RA.